Literature DB >> 15165826

Multiple signal transducers and activators of transcription are induced by EBV LMP-1.

Luwen Zhang1, Ke Hong, Jun Zhang, Joseph S Pagano.   

Abstract

Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) is required for EBV immortalization of primary B cells in vitro. Signal transducers and activators of transcription (STATs) play a pivotal role in the initiation and maintenance of certain cancers. STAT proteins, especially STAT-1, -3, and -5, are persistently tyrosine phosphorylated or activated in many cancers. We show here that EBV-infected type III latency cells, in which the EBV oncoprotein, LMP-1 is expressed, express high levels of four STATs (STAT-1, -2, -3, and -5A) and that LMP-1 is responsible for the induction of three (STAT-1, -2, and -3). In addition, the C-terminal activator region 1 (CTAR-1) and CTAR-2 of LMP-1 cooperatively induced the expression of STAT-1. The cooperativity was evident when CTAR-1 and CTAR-2 were present in cis, but not in trans. Furthermore, NF-kappaB is an essential factor involved in the induction of STAT-1. Most of the induced STATs were not phosphorylated at the critical tyrosine residue activated by many cytokines. However, the induced STATs, at least STAT-1, were functional because it could be activated by interferon (IFN) and could upregulate an IFN-inducible gene. Finally, expression of STAT-1, but not STAT-2 and -3, is associated with EBV transformation. The association of the expression of STAT-1, -2, -3, and -5A with EBV type III latency and the expression of STAT-1 in the EBV transformation process may be part of the viral programming that regulates viral latency and cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165826     DOI: 10.1016/j.virol.2004.03.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

Review 1.  The viral etiology of AIDS-associated malignancies.

Authors:  Peter C Angeletti; Luwen Zhang; Charles Wood
Journal:  Adv Pharmacol       Date:  2008

2.  B lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferation.

Authors:  Siva Koganti; Amanda de la Paz; Alexandra F Freeman; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

3.  Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Authors:  Yong Zhao; Dongsheng Xu; Yanjun Jiang; Luwen Zhang
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

4.  A novel variant in STAT2 presenting with hemophagocytic lymphohistiocytosis.

Authors:  Mohammed F Alosaimi; Michelle C Maciag; Craig D Platt; Raif S Geha; Janet Chou; Lisa M Bartnikas
Journal:  J Allergy Clin Immunol       Date:  2019-05-15       Impact factor: 10.793

5.  Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.

Authors:  Imen Najjar; Fanny Baran-Marszak; Christophe Le Clorennec; Christelle Laguillier; Olivier Schischmanoff; Ibtissam Youlyouz-Marfak; Martin Schlee; Georg W Bornkamm; Martine Raphaël; Jean Feuillard; Remi Fagard
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.

Authors:  Qianli Wang; Amy Lingel; Vicki Geiser; Zachary Kwapnoski; Luwen Zhang
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

7.  Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.

Authors:  Katherine Cosmopoulos; Michiel Pegtel; Jared Hawkins; Howell Moffett; Carl Novina; Jaap Middeldorp; David A Thorley-Lawson
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

8.  Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Authors:  Dongsheng Xu; Lingjun Zhao; Luis Del Valle; Judith Miklossy; Luwen Zhang
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

Authors:  Tianli Xia; Andrea O'Hara; Iguaracyra Araujo; Jose Barreto; Eny Carvalho; Jose Bahia Sapucaia; Juan Carlos Ramos; Estela Luz; Celia Pedroso; Michele Manrique; Ngoc L Toomey; Carlos Brites; Dirk P Dittmer; William J Harrington
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

10.  TLR-TRIF pathway enhances the expression of KSHV replication and transcription activator.

Authors:  Florencia Meyer; Erica Ehlers; Andrew Steadman; Thomas Waterbury; Mingxia Cao; Luwen Zhang
Journal:  J Biol Chem       Date:  2013-05-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.